Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

GFC is more effective than PRP for treating hair loss.

This study found that eyebrow mesotherapy with a growth factor-based serum improved eyebrow width, length, density, and psychosocial outcomes such as social engagement, quality of life, confidence, and mood in individuals with sparse or weakened eyebrows.

In this open-label study of post-menopausal women with frontal fibrosing alopecia, researchers found that 12 weeks of baricitinib monotherapy significantly reduced disease activity as measured by the Lichen Planopilaris Activity Index, improved patient-reported scalp hair growth, but showed no significant change in eyebrow growth.

In this study, 49% of patients with alopecia areata achieved a significant response to baricitinib, with a lower baseline severity, shorter disease duration, and longer treatment duration identified as significant predictors of treatment success.

This study concluded that platelet-rich plasma significantly improves hair density and patient satisfaction for individuals undergoing follicular unit extraction for androgenetic alopecia compared to those receiving the surgery alone.

RF-mesotherapy with bicalutamide may be a promising new treatment for hair loss.

In this study, microneedling followed by topical 2% chitosan significantly improved hair growth parameters in patients with androgenetic alopecia, comparable to results with 5% minoxidil, but a small sample size limits definitive conclusions on their relative efficacy.

This study found that 20% mung bean seed coat extract effectively stimulates hair growth in New Zealand White rabbits, demonstrating results close to minoxidil 2% in terms of hair length, weight, and growth area, suggesting its potential as a natural alternative for hair loss therapy.

The study found that a pomade containing bay leaf extract significantly promoted hair growth in New Zealand White rabbits, with the 30% extract formula demonstrating the highest growth compared to lower concentrations and a control without extract.

In this study, researchers found no significant differences in serum levels of ferritin, folate, vitamin B12, vitamin D, or thyroid function between patients with scarring alopecia and healthy controls, suggesting these factors may not play a major role in the disease's pathogenesis.

In this retrospective chart review, researchers found that keratinocyte carcinomas on the scalp and forehead of non-alopecic women occurred more frequently in the part line of the scalp, with basal cell carcinoma being more common than squamous cell carcinoma.

This study found that both 2.5 mg/mL and 5 mg/mL concentrations of intralesional triamcinolone acetonide are effective for treating patchy alopecia areata, but the higher concentration promoted greater hair regrowth and density with more side effects.

In this study, researchers using Astral—DIA proteomics technology identified 67 differentially expressed proteins in Gansu alpine fine-wool sheep, linking proteins like keratin and MGST3 in pathways to wool fineness regulation, particularly highlighting their association with hair follicle development.

This study found that a novel dietary supplement, AGA-P, when combined with minoxidil and finasteride, significantly improved the clinical efficacy of these drugs for treating mild-to-severe androgenic alopecia compared to drug treatment alone over six months.

This study found that microneedling treatment improved hair regeneration in an animal model of alopecia areata and positively influenced the gut microbiome by restoring microbial diversity and altering short-chain fatty acid levels.

This study found that combining topical minoxidil with phototherapy significantly improved pigmentation and reduced vitiligo severity compared to placebo, as measured by VASI scores over 12 weeks, though the sample size was small and follow-up short.

This systematic review found that topical adenosine may increase hair thickness and density while reducing hair loss, but the strength of evidence is low due to issues with trial design and sample size.

This study concluded that platelet-rich plasma is nearly as effective as topical minoxidil for treating androgenetic alopecia, with PRP improving hair density and minoxidil boosting terminal hair count.

In this systematic review and meta-analysis, the authors examined single-spin versus double-spin centrifugation protocols for PRP in patients with androgenic alopecia and found no significant difference in platelet concentration, hair density, or hair types between the protocols.

This study found no significant differences in platelet concentration or hair growth outcomes between single-spin and double-spin PRP centrifugation methods for treating androgenic alopecia, suggesting that the simpler single-spin approach may be preferable.

In this randomized controlled trial, researchers observed that topical clobetasol propionate 0.05% was significantly more effective than topical tacrolimus 0.1% for treating alopecia areata, with a higher treatment success rate of 74.2% versus 45.2%, suggesting clobetasol as a preferred first-line topical therapy.

This study concluded that the effectiveness and safety of a domestic follicular extraction system were similar to conventional follicular unit excision in patients undergoing hair transplant surgery for androgenetic alopecia.

This study found no significant link between the length of CAG repeats in the AR gene and the risk of polycystic ovary syndrome in Iranian women.

This study evaluated a herbal oil derived from plant extracts for hair growth, finding it significantly accelerated hair growth in an animal model compared to controls, suggesting it as a natural and safe alternative to synthetic treatments with minimized side effects.

This study found that oral tofacitinib was significantly more effective than oral minoxidil in reducing disease severity and improving treatment response in patients with alopecia areata over a 12-week period.

In this study, a daily low-dose regimen of oral minoxidil and finasteride over 12 months led to significant hair density improvements in over 92% of adult men with androgenetic alopecia, including those with advanced stages, though inter-rater reliability in photo assessments was modest.

This study found that both intralesional minoxidil 8% and botulinum toxin type A were equally effective in treating female pattern hair loss, with no significant difference in results between the two treatments.

In this study, researchers found that activating RORA in hair follicle stem cells reduced the expression of cytoskeleton-related genes, affecting cell migration and adhesion, which may aid in understanding hair follicle development and potentially inform alopecia treatments.

This study reported that etrasimod did not achieve significant improvements in hair regrowth for moderate to severe alopecia areata at 24 weeks, although it showed a dose-dependent trend and was safe and well-tolerated over 52 weeks.

Results are not provided in this abstract. It discusses a comparison between the efficacy of minoxidil alone and in combination with low-level laser therapy for treating androgenic alopecia.